PACS Group (PACS) Competitors $12.80 -0.39 (-2.92%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$12.82 +0.02 (+0.16%) As of 02/21/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PACS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, LFST, PRVA, and CONShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), LifeStance Health Group (LFST), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. PACS Group vs. Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Veracyte LifeStance Health Group Privia Health Group Concentra Group Holdings Parent Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation. Do analysts prefer GH or PACS? Guardant Health presently has a consensus price target of $44.78, suggesting a potential upside of 4.45%. PACS Group has a consensus price target of $34.00, suggesting a potential upside of 165.52%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 3.00PACS Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Does the MarketBeat Community favor GH or PACS? Guardant Health received 265 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 70.59% of users gave Guardant Health an outperform vote. CompanyUnderperformOutperformGuardant HealthOutperform Votes28870.59% Underperform Votes12029.41% PACS GroupOutperform Votes2395.83% Underperform Votes14.17% Does the media prefer GH or PACS? In the previous week, Guardant Health had 25 more articles in the media than PACS Group. MarketBeat recorded 28 mentions for Guardant Health and 3 mentions for PACS Group. PACS Group's average media sentiment score of 0.39 beat Guardant Health's score of 0.32 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral PACS Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is GH or PACS more profitable? PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -59.05%. PACS Group's return on equity of 0.00% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-59.05% -19,157.20% -25.96% PACS Group N/A N/A N/A Do institutionals and insiders believe in GH or PACS? 92.6% of Guardant Health shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has better valuation and earnings, GH or PACS? PACS Group has higher revenue and earnings than Guardant Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M7.17-$479.45M-$3.56-12.04PACS Group$3.11B0.63$112.87MN/AN/A SummaryPACS Group beats Guardant Health on 8 of the 15 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$2.01B$2.70B$5.83B$20.22BDividend YieldN/A1.31%4.75%3.64%P/E RatioN/A12.9026.8134.95Price / Sales0.630.91428.3217.44Price / CashN/A12.2638.0120.26Price / BookN/A2.767.644.80Net Income$112.87M$120.70M$3.19B$1.02B7 Day Performance-4.52%-3.66%-2.13%-1.14%1 Month Performance-11.32%-5.67%-1.11%-1.66%1 Year PerformanceN/A0.84%15.71%13.43% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group4.0138 of 5 stars$12.81-2.9%$34.00+165.5%N/A$2.01B$3.11B0.0032,433News CoverageGHGuardant Health4.2109 of 5 stars$48.12+2.4%$42.63-11.4%+92.5%$5.95B$563.95M-11.351,779Earnings ReportAnalyst ForecastNews CoverageGap UpOPCHOption Care Health4.1033 of 5 stars$31.46-1.1%$32.25+2.5%-1.7%$5.35B$4.30B26.447,802Upcoming EarningsPositive NewsRDNTRadNet3.8879 of 5 stars$61.33-1.9%$75.50+23.1%+52.7%$4.54B$1.62B-876.0210,288BTSGBrightSpring Health Services1.7482 of 5 stars$22.05-0.1%$19.42-11.9%+98.7%$3.84B$10.59B-84.8135,000SHCSotera Health2.1791 of 5 stars$13.48+0.4%$16.08+19.3%-18.6%$3.82B$1.05B53.923,000Analyst ForecastNews CoverageNegative NewsSGRYSurgery Partners3.3084 of 5 stars$25.87+0.3%$36.56+41.3%-23.0%$3.29B$2.74B-53.9013,500Upcoming EarningsPositive NewsVCYTVeracyte2.9071 of 5 stars$41.11+3.8%$42.00+2.2%+61.0%$3.19B$361.05M-274.07790Upcoming EarningsAnalyst DowngradeNews CoverageLFSTLifeStance Health Group1.5311 of 5 stars$7.97-0.3%$8.70+9.2%+23.0%$3.05B$1.21B-30.659,325Upcoming EarningsNews CoveragePRVAPrivia Health Group3.2581 of 5 stars$25.24+1.5%$24.94-1.2%+23.8%$3.03B$1.72B252.431,102News CoverageCONConcentra Group Holdings ParentN/A$22.69-0.6%$28.63+26.1%N/A$2.89B$1.84B0.0011,000Positive News Related Companies and Tools Related Companies GH Alternatives OPCH Alternatives RDNT Alternatives BTSG Alternatives SHC Alternatives SGRY Alternatives VCYT Alternatives LFST Alternatives PRVA Alternatives CON Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:PACS) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.